European Urology Oncology

Slides:



Advertisements
Similar presentations
The Proteome of Primary Prostate Cancer
Advertisements

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer  Philippe O. Gannon, Laurent Lessard, Louis-Mathieu.
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Inflammatory Protein Serum Amyloid A1 Marks a Subset of Conventional Renal Cell Carcinomas with Fatal Outcome  Claudia Paret, Zorica Schön, Adrianna Szponar,
European Urology Focus
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Volume 62, Issue 5, Pages (November 2012)
Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer  C.E. Henry, C. Emmanuel, N.
Volume 52, Issue 1, Pages (July 2007)
European Urology Oncology
Volume 60, Issue 1, Pages (July 2011)
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Ayesha A. Shafi, Matthew J
Lu Chen, PhD, Brienne E. Engel, PhD, Eric A. Welsh, PhD, Sean J
Microarray-Based Prediction of Tumor Response to Neoadjuvant Radiochemotherapy of Patients With Locally Advanced Rectal Cancer  Caroline Rimkus, Jan Friederichs,
Kenneth G. Geles, Wenyan Zhong, Siobhan K
Volume 58, Issue 1, Pages (July 2010)
European Urology Oncology
Volume 72, Issue 4, Pages (October 2017)
European Urology Oncology
The Proteome of Primary Prostate Cancer
Volume 70, Issue 5, Pages (November 2016)
Volume 74, Issue 5, Pages (November 2018)
European Urology Oncology
European Urology Oncology
Laurent Boccon-Gibod  European Urology Supplements 
Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients  Timo F.W. Soeterik,
The PSA Era is not Over for Prostate Cancer
Molecular Tumour Profiling for Detection of Biomarkers in Renal Cell Tumours  Kerstin Junker, Jimsgene Sanjmyatav, Joerg Mueller, Thomas Steiner, Heiko.
European Urology Oncology
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Mark A. Rubin, Gabriele Girelli, Francesca Demichelis  European Urology 
European Urology Oncology
Volume 72, Issue 4, Pages (October 2017)
Volume 65, Issue 1, Pages (January 2014)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
Volume 53, Issue 6, Pages (June 2008)
Learning More from Microarrays: Insights from Modules and Networks
Volume 9, Issue 4, Pages (November 2014)
Volume 71, Issue 5, Pages (May 2017)
Study design. Study design. (A) Hematoxylin and eosin staining of the fresh frozen prostate tissue from three individuals who have contributed to BPH (non-tumorous)
Histopathological diagnosis of Japanese spotted fever using formalin-fixed, paraffin- embedded skin biopsy specimens Usefulness of immunohistochemistry.
European Urology Oncology
Volume 9, Issue 1, Pages (July 2017)
Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression  Mohamed T. Ghorbel,
European Urology Oncology
Volume 4, Issue 3, Pages (August 2013)
European Urology Oncology
Volume 49, Issue 6, Pages (June 2006)
PD-1 expression on HCC-infiltrating B cells and its clinical significance. PD-1 expression on HCC-infiltrating B cells and its clinical significance. A–H,
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances  Florian Cabillic, PharMD, PhD,
Volume 22, Issue 3, Pages (January 2018)
Bicuspid Aortic Valve Morphotype Correlates With Regional Antioxidant Gene Expression Profiles in the Proximal Ascending Aorta  Julie A. Phillippi, PhD,
European Urology Oncology
European Urology Oncology
Volume 67, Issue 5, Pages (November 2017)
European Urology Oncology
European Urology Oncology
Increased μ-opioid receptor expression in metastatic lung cancer
Genetics of hepatocellular carcinoma: The next generation
A user's perspective on GeoMxTM digital spatial profiling
Volume 2, Issue 3, Pages (March 2016)
CXCL14-positive CAFs induce overexpression of LINC00092 in ovarian cancer. CXCL14-positive CAFs induce overexpression of LINC00092 in ovarian cancer. A,
Heat map of genes for which CR significantly altered expression versus AL. Cluster analysis of genes significantly changed by the CR intervention compared.
Salvage Local Treatments After Focal Therapy for Prostate Cancer
FILM immunohistochemical protein signature is significantly associated with poor survival. FILM immunohistochemical protein signature is significantly.
Driver pathways and key genes in OSCC
Transcriptome profiling of PD-L1 antibody–treated macrophages showed inflammatory phenotype, increased survival and proliferation, and decreased apoptosis.
Presentation transcript:

European Urology Oncology Individual Comparison of Cholesterol Metabolism in Normal and Tumour Areas in Radical Prostatectomy Specimens from Patients with Prostate Cancer: Results of the CHOMECAP Study  Olivier Celhay, Laura Bousset, Laurent Guy, Jean-Louis Kemeny, Valerio Leoni, Claudio Caccia, Amalia Trousson, Christelle Damon- Soubeyrant, Angélique De Haze, Laura Sabourin, Catherine Godfraind, Cyrille de Joussineau, Bruno Pereira, Laurent Morel, Jean Marc Lobaccaro, Silvère Baron  European Urology Oncology  DOI: 10.1016/j.euo.2018.08.001 Copyright © 2018 Terms and Conditions

Fig. 1 After radical prostatectomy, samples of normal and tumour tissues were collected from each organ and frozen. Prostate specimens were retrospectively fixed, paraffin-embedded, and stained with haematoxylin and eosin. Three examples are shown. Normal tissue (blue) and carcinoma (red) areas in samples were confirmed by a pathologist to validate the sample collection. Tissues were then processed for gene analysis, sterol measurement, and immunohistochemistry. European Urology Oncology DOI: (10.1016/j.euo.2018.08.001) Copyright © 2018 Terms and Conditions

Fig. 2 Graphical summary of individual comparisons of tumour and normal tissues. The cholesterol pathway is represented by three boxes: the mevalonate pathway, cholesterol homeostasis, and cholesterol oxidation. Gene expression and metabolites showing significant differences are indicated in green for downregulation and red for upregulation. The magnitude of changes is indicated as a percentage. European Urology Oncology DOI: (10.1016/j.euo.2018.08.001) Copyright © 2018 Terms and Conditions

Fig. 3 Haematoxylin and eosin (left) and SCARB1 immunostaining (right) for two examples of normal and tumour prostate tissues pairs. The boxplot shows the H-scores for SCARB1 staining in both tissues. ** p≤0.01. The histogram depicts the difference in SCARB1 H-score between tumour and normal tissues for each individual patient. The red line indicates the median H-score. European Urology Oncology DOI: (10.1016/j.euo.2018.08.001) Copyright © 2018 Terms and Conditions

Fig. 4 Principal component analysis for gene expression results. Global vectors are shown for tumour and normal tissues using red and blue areas, respectively, and the heading for each vector denotes genes with the most deregulated expression in the tissue pairs. Deep blue/red circles indicate genes involved in de novo cholesterol synthesis that form an aggregated cluster. European Urology Oncology DOI: (10.1016/j.euo.2018.08.001) Copyright © 2018 Terms and Conditions